Synergy Pharmaceuticals Inc (SGYP.O)

SGYP.O on Nasdaq

3.95USD
11 Jul 2014
Price Change (% chg)

$0.10 (+2.60%)
Prev Close
$3.85
Open
$3.86
Day's High
$4.01
Day's Low
$3.84
Volume
601,892
Avg. Vol
1,198,227
52-wk High
$6.70
52-wk Low
$3.39

SGYP.O

Chart for SGYP.O

About

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company’s lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and... (more)

Overall

Beta: 0.53
Market Cap (Mil.): $360.74
Shares Outstanding (Mil.): 93.70
Dividend: --
Yield (%): --

Financials

  SGYP.O Industry Sector
P/E (TTM): -- 99.11 35.83
EPS (TTM): -0.66 -- --
ROI: -153.14 -0.58 18.29
ROE: -169.84 -1.43 19.18
Search Stocks

Synergy Pharma constipation drug succeeds in trial

- Synergy Pharmaceuticals Inc said its constipation drug improved the frequency of complete spontaneous bowel movements in patients with a form of irritable bowel syndrome, reinforcing investor hopes that the data would boost chances of a buyout.

30 Apr 2014

UPDATE 2-Synergy Pharma constipation drug succeeds in trial

April 30 - Synergy Pharmaceuticals Inc said its constipation drug improved the frequency of complete spontaneous bowel movements in patients with a form of irritable bowel syndrome, reinforcing investor hopes that the data would boost chances of a buyout.

30 Apr 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks